Objective: Obesity is associated with a variety of diseases, which results in a decreased overall life expectancy. Nevertheless, some studies suggest that being overweight may reduce hospital mortality of certain patient groups, referred to as obesity paradox. Conflicting results for critically ill patients are reported. Therefore, we wished to investigate the association of body mass index and hospital mortality in critically ill patients. Design: Observational cohort study in Dutch critically ill patients. Setting: A dataset from the Dutch National Intensive Care Evaluation registry that includes patients admitted to Dutch ICUs was used. Patients: One hundred fifty-four thousand three hundred and eight ICU patients of teaching and nonteaching units in urban and nonurban hospitals. Interventions: None. Measurements and Main Results: We used logistic regression analysis, correcting for case mix (Simplified Acute Physiology Score II, age, gender, admission type, neoplasm, AIDS, hematologic malignancy, immunologic insufficiency, mechanical ventilation, and calendar year), to determine the relationship between body mass index and hospital mortality. Body mass index was included in the model as a continuous nonlinear covariate in a restricted regression spline transformation. To facilitate interpretation, adjusted odds ratios were calculated for the World Health Organization-based body mass index classes. Body mass index was found to be significantly associated with hospital mortality, with risks quickly increasing for underweight patients (body mass index < 18.5 kg/m 2 ). Obese and seriously obese patients, with a body mass index of 30-39.9 kg/m 2 , had the lowest risk of death with an adjusted odds ratio of 0.86 (0.83-0.90). Conclusions: This large observational database shows an inverse association between obesity and hospital mortality in critically ill patients that could not be explained by a variety of known confounders. (Crit Care Med 2013; 41:1878-1883 
A s the obesity pandemic continues to expand, critical caregivers are faced with more and more obese, critically ill patients. Increased risks of developing metabolic syndrome, diabetes, cardiovascular disease, respiratory dysfunction, and cancer are directly associated with the premature death observed among the obese. In the general population, body mass index (BMI) in itself represents a strong predictor of the overall mortality rate both above and below the optimum BMI of approximately 23-25 kg/m 2 (1, 2). In contrast, several studies show that obesity may result in a lower mortality rate in some patient groups after hospital admission (3) (4) (5) , a finding called the obesity paradox (6, 7) .
Conflicting data concerning the association between the BMI and the mortality rate of patients admitted to the ICU have been reported. On one hand, it is thought that physiologic changes in obese patients may impair the ability to adapt to the stresses of critical illness, whereas on the other hand, obese patients may have more metabolic reserves (8) or immunologic benefits (9) to survive their critical illness. Previous studies of critically ill patients have found no significant beneficial effect of a higher BMI on the mortality rate, whereas others have found detrimental effects. In three recent meta-analyses including data for approximately 62,000 (10) , 74,400 (11) , and 88,000 (12) to have a comparable or longer length of stay in the ICU, while hospital mortality rate was lower only by dichotomous analysis in the third meta-analysis (12) , when patients with a BMI less than 30 were compared with those with a BMI greater than or equal to 30 kg/m 2 . Although these data suggest that a higher BMI may exert some beneficial effects on critically ill patients, the studies included in the meta-analyses suffered from statistical heterogeneity, results were not corrected for other prognostic covariates, and publication bias may have influenced the results.
In this study, we established the association between BMI and hospital mortality rate as well as ICU and hospital length of stay in a large observational database of patients in intensive care.
MATERIALS AND METHODS

Patient Data
A dataset from the Dutch National Intensive Care Evaluation (NICE) registry that includes patients admitted to the Dutch ICUs from January 1, 1999, to January 1, 2010, was used in this study. Sixty-two ICUs, teaching and nonteaching in nonurban and urban hospitals in the Netherlands, participated. We only included ICUs that recorded BMI for more than 75% of their patients. The data were encrypted by the removal of all patientidentifying information. In the Netherlands, there is no need to obtain consent to use such registries with anonymous data. The NICE initiative is officially registered in conformance to the Dutch Personal Data Protection Act. This study has been carried out in the Netherlands in accordance with the applicable rules concerning the review of research ethics committees and informed consent. Data collection took place in a standardized manner according to strict definitions and was subject to stringent data quality checks (13) .
The patient data collected during the first 24 hours after admission to an ICU include height (cm), weight (kg), and severity of illness. We calculated the BMI for each patient. We used the Simplified Acute Physiology Score (SAPS) II for casemix adjustment because this scoring system fits best with the patient population of the NICE registry (14) .
Patients admitted after cardiac surgery, patients admitted with severe burns, patients younger than 18 years, with missing height and/or weight data, or patients with reported BMI less than 10 kg/m2 or greater than 55 kg/m 2 were excluded. If a patient was admitted to the ICU more than once during a hospitalization period, only data of the first ICU admission were used (13) .
The primary outcome measure was the adjusted in-hospital mortality rate. Secondary outcome measures included the lengths of ICU and hospital stays.
Statistical Analysis
We assessed the relationship between BMI and the hospital mortality rate with multivariate logistic regression analysis. Potential confounders of the association of BMI with the hospital mortality rate (SAPS II, age, gender, admission type, neoplasm, AIDS, hematologic malignancy, immunologic insufficiency, mechanical ventilation, and calendar year) were included in the model. The BMI was included in the model as a continuous nonlinear predictor in a restricted regression spline transformation. Regression splines allow estimation of a nonlinear relationship between a predictor and an outcome and replace less accurate techniques that assume the relationship is linear (15, 16) . The likelihood ratio test was used to establish the appropriate order of the spline transformation in comparing quadratic, cubic, and higher order splines. Eventually, the resulting model was statistically compared with a baseline model without BMI but including the confounders, also using the likelihood ratio test.
To facilitate interpretation of the results, in subsequent analyses, BMI was divided into six categories on the basis of the National Institutes of Health and the World Health Organization criteria for BMI: underweight (< 18.5 kg/m²), normal weight (18.5-24.9 kg/m²), overweight (25.0-29.9 kg/ m²), obesity (30.0-34.9 kg/m²), serious obesity (35.0-39.9 kg/ m²), and morbid obesity (> 40.0 kg/m²).
Differences in lengths of ICU and hospital stays between BMI categories were compared by the nonparametric KruskalWallis test. In the comparison, it was assumed that patients who died had an infinite length of stay.
SPSS version 16.0 (SPSS, Chicago, IL) and Spotfire S+ 8.1 (TIBCO Software, Palo Alto, CA) (17) were used for all statistical analyses.
RESULTS
Demographic Characteristics of Critically Ill Patients
During the 10-year period, 167,286 patients included in the NICE registry fulfilled the SAPS II inclusion criteria. In total, BMI values were missing for 11,527 patients (6.9%) and recorded as less than 10 kg/m 2 or more than 55 kg/m 2 for 1,451 patients (0.9%). These patients were excluded, resulting in a final dataset of 154,308 patients admitted to intensive care. A total of 21,203 patients (13.6%) died during their ICU stay, and 31,628 patients (20.3%) died during their hospital admission. Crude ICU mortality decreased from 16.2% in 1999 to 12.2% Table 1 lists the demographic characteristics, grouped in the six BMI categories. Obese patients were more often admitted because of surgery, were younger, and were more likely to be women, compared with those with a low or normal BMI. A greater proportion of obese patients received vasoactive drugs and/or mechanical ventilation than did other patients. There was no apparent association between BMI and the SAPS II. Table 2 lists the estimated odds ratios of the confounding variables in the logistic regression model. We chose a natural spline basis for BMI with two degrees of freedom because it proved to be superior to a linear model, whereas a higher order natural spline transformation did not significantly improve the model. Calendar time was significantly associated with mortality after correcting for all other factors in the model; however, inclusion of calendar year in the analysis did not affect the estimated association between BMI and mortality. Figure 2 shows the estimated association of BMI and the mortality rate when a BMI of 25.0 is used as the reference category. The relative risks of death follow an inverse J shape, with a minimal risk (relative risk = 0.37) for patients with a BMI of 42.6, and they quickly increase for patients with a BMI less than 20.0 kg/m 2 . Table 3 lists the differences in outcome among BMI categories and adjusted odds ratios estimated by the model and averaged per BMI category. Differences in lengths of stay between BMI categories were statistically significant (p < 0.01); however, correction for case mix was not possible and data were truncated for patients who died.
Confounders and Association Between BMI and the Mortality Rate
DISCUSSION
Obese patients may have led a less healthy lifestyle, and they present the clinician with obstacles to successful treatment, especially during critical illness. These circumstances do not appear to affect their outcomes negatively once they become critically ill. Our findings provide further confirmation of the existence of the obesity paradox for critically ill patients, and they are the first to show that a BMI above 35 kg/m 2 is associated with a significantly lower hospital mortality rate independently of other known prognostic factors. Three previous meta-analyses, combining data of up to 88,000 patients in intensive care, and a recent study in approximately 10,000 surgical ICU patients (18) suggested that there was an obesity-related survival benefit, but there were no firm conclusions concerning the effect of BMI on the overall mortality rate. These meta-analyses were statistically very heterogeneous, which indicates the need for caution in interpreting pooled estimates. Importantly, adjustments, for example, severity of illness and age were not applied, and some studies reported more than 30% of the data missing, compared with 7.8% of the patients in our study. Our database of over 150,000 patients now makes it clear that an inverse J-shaped outcome association with BMI for critically ill patients actually exists, and the mortality rate is greatest for patients with cachexia. This rate becomes progressively lower for normal, overweight, and obese patients and only tends to increase again for patients who are morbidly obese. The optimal BMI for critically ill patients appears to be higher than that of patients whose illness is not critical (19) . There are several limitations inherent to the observational nature of our study. Some may argue that these observational associations are not real phenomena but reflect selection bias with the more severe patients or those with poorer prognoses. That is to say, due to the presence of, for example, malignancies, they have lower BMIs as an epiphenomenon of their poorer outcomes. Furthermore, obese patients who are less ill may be admitted earlier to the ICU because of the need for more nursing staff not available on the ward. This could affect the unadjusted data presented in the previous meta-analyses but appears to be less important in the adjusted data of this study. Although it is likely that unmeasured or residual confounding factors remain, adjusted odds ratios in our analysis show that BMI influences outcome independently of gender, neoplasm, and severity of disease. Importantly, the distribution of , also arguing against bias. In addition, our study shows that reverse causality (e.g., when occult or preexisting diseases [such as cancer] that increase mortality also cause weight loss) does not explain the higher mortality rate of patients with a lower BMI. Naturally, our study is not suited to explain the mechanism of the observed beneficial effect of obesity, and we are not able to determine whether body fat distribution modifies the observed association. Previous studies have shown that after adjustment for BMI, waist circumference and the waistto-hip ratio were strongly associated with the risk of death for nonhospitalized patients (1), whereas a higher mortality rate was observed for adults with a thigh circumference less than 60 cm (22) .
Thus, although obesity is associated with various comorbid conditions, physiologic derangements, physical limitations, and pharmacologic alterations, all of which may complicate acute illness and impede therapeutic measures, obese patients still have a better outcome. This may not be as counterintuitive as it seems when we consider that, during human evolution, a better nutritional state enabled people to overcome periods of physical crisis. Nevertheless, this does not explain the mechanism or nature of the potential protective factors, and the influence of obesity on acute illnesses is still poorly understood. Several explanations have been put forward to explain the apparently beneficial effects of obesity on critically ill patients, including more nutritional reserves, higher levels of anti-inflammatory cytokines (9, 23) , and the higher cholesterol and lipid levels common in obese patients, which bind endotoxin during critical illness and provide the precursors for adrenal steroid synthesis (24) . In addition, neutrophil dysfunction, attenuation of acute lung injury (25) , and diaphragmatic remodeling due to chronically increased weight (26) and chronically increased intra-abdominal pressure (27) are possibly related to a lower acute respiratory distress syndrome prevalence in obese patients (28) . It has been estimated that 20% of the world's population is currently overweight and that nearly 300 million people are obese (29) . Given the rising prevalence of obese patients in the ICU, understanding the consequences of obesity for critical illness has great public health importance. Our study shows that the nadir of the mortality risk for critically ill patients is in the seriously obese range and that further research is warranted to determine the pathophysiologic mechanisms of this observation. The odds ratio represents the association (risk-adjusted for the Simplified Acute Physiology Score II, gender, and neoplasm) between the body mass index (kg/m²) categories and the hospital mortality rate.
